Publish date: 27 July 2022
The use of polymerase chain reaction (PCRs) for patient COVID-19 testing has now reduced and has, for the majority of instances, been replaced by lateral flow device (LFD) tests. PCRs will continue to be used for: day one admission tests, testing in outbreaks, symptomatic testing and patient transfers to care homes or other trusts, if requested. All other tests will now be performed using LFDs. All results of LFD tests must be inputted onto the patient clinical record system.
For further details, specific examples, recording and reporting of results, and stocks, please read the updated standard operating procedure: Patient testing using Lateral Flow Devices (LFDs)
Please share this information with colleagues who don’t regularly access a PC.